United States Human Milk Oligosaccharides Market Size & Outlook, 2026-2034
Last Updated : 18 June, 2026 |
Study Period : 2022-2034 |
Format : PDF, Excel |
Author : Hannah Blake
United States Human Milk Oligosaccharides Market Insights
- As per Deep Market Insights insights, the United States Human Milk Oligosaccharides Market stood at USD 110.6 Million in 2025 and is anticipated to grow to USD 459.1 Million by 2034.
- The United States market is expected to advance at a CAGR of 17.32% from 2026 through 2034.
- In 2025, 2-Fucosyllactose (2-FL) accounted for the highest share of the Product Type market size.
- During the forecast period, Others is set to register the highest growth, making it the most lucrative Product Type segment.
![United States Human Milk Oligosaccharides Market Size, Share & Growth Report By [2034]](https://deepmarketinsights.com/uploads/charts/united-states-human-milk-oligosaccharides-market-united-states-product-type-119923.png)
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- In 2025, United States represented 31.8% of the overall global Human Milk Oligosaccharides Market size.
- United States is projected to lead the global Human Milk Oligosaccharides Market size by 2034.
- Across North America, United States is anticipated to hold the dominant position in market size by 2034.
- Canada is forecasted to expand at the fastest pace in North America, attaining USD 122.09 Million by 2034.
United States Human Milk Oligosaccharides Market Product Type 2026-2034 (USD Million)
| Product Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2-Fucosyllactose (2-FL) | XX.x | XX.x | XX.x | 45.45 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| 3-Fucosyllactose (3-FL) | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Lacto-N-neotetraose (LNnT) | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Others | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | 110.60 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
United States Human Milk Oligosaccharides Market Application 2026-2034 (USD Million)
| Application | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infant formula | XX.x | XX.x | XX.x | 53.87 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Dietary supplements | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Functional foods and beverages | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Animal nutrition | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | 110.61 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
United States Human Milk Oligosaccharides Market Form 2026-2034 (USD Million)
| Form | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dry | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Liquid | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
United States Human Milk Oligosaccharides Market End user 2026-2034 (USD Million)
| End user | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infant nutrition manufacturers | XX.x | XX.x | XX.x | 59.18 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Nutraceutical manufacturers | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Food and beverage companies | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | 110.62 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 110.6 Million |
| Market Size In 2034 | USD 459.1 Million |
| Largest segment | 2-Fucosyllactose (2-FL) |
| Units | Revenue in USD Million |
| CAGR | 17.32% (2026-2034) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |